Año: 2023
Journal Impact Factor (JIF): 3.60
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CLINICAL NEUROLOGY | SCIE | 67/280 | Q1 | T1 | D3 |
| GENETICS & HEREDITY | SCIE | 57/191 | Q2 | T1 | D3 |
Año: 2023
Journal Citation Indicator (JCI): 0,970
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CLINICAL NEUROLOGY | 81/281 | Q2 | T1 | D3 | 71,35 |
| GENETICS & HEREDITY | 50/191 | Q2 | T1 | D3 | 74,08 |
Año:
2023
CiteScore:
6,300
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Neurology (clinical) | 94/400 | Q1 | T1 | D3 |
| Genetics (clinical) | 34/99 | Q2 | T2 | D4 |
SJR año:
2023
Factor de Impacto:
1,042
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Neurology (clinical) | 92/398 | Q1 | T1 | D3 |
| Genetics (clinical) | 34/99 | Q2 | T2 | D4 |
| Agencia | Código de Proyecto |
|---|---|
| ALS Association | 20-IIA-532; 20-IIA-532 |
| Dr. Randall W. Whitcomb Fund for ALS Genetics | - |
| Intramural Research Program of the NIH | - |
| National ALS Registry/CDC/ATSDR | 1R01TS000289; 1R01TS000289 |
| National ALS Registry/CDC/ATSDR CDCP-DHHS-US | CDC/ATSDR 200-2013-56856; CDC/ATSDR 200-2013-56856 |
| National Institute on Aging | Z01-AG000949-02; Z01-AG000949-02 |
| Neuro Network for Emerging Therapies at the University of Michigan | - |
| NIEHS | K23ES027221; R01ES030049; K23ES027221; R01ES030049 |
| NINDS | R01NS127188; R01NS127188 |
| Peter R. Clark Fund for ALS Research | - |
| Project "ALS Genetic study in Madrid Autonomous Community - ESTRATEGIAS FRENTE A ENFER-MEDADES NEURODEGENERATIVAS" from Spanish Ministry of Health | - |
| Scott L. Pranger ALS Clinic Fund | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Dou, JH | University of Michigan (USA) |
| 2 | Bakulski, K | University of Michigan (USA) |
| 3 | Guo, K | University of Michigan (USA) |
| 4 | Hur, J | Univ North Dakota (Canada) |
| 5 | Zhao, LL | University of Michigan (USA) |
| 6 | Saez-Atienzar, S | NIH National Institute on Aging (NIA) (USA) |
| 7 | Stark, A | NIH National Institute on Aging (NIA) (USA) |
| 8 | Chia, RT | NIH National Institute on Aging (NIA) (USA) |
| 9 | García-Redondo, A | Hospital Universitario 12 de Octubre; CIBERER (Spain) |
| 10 | Rojas-Garcia, R | Hospital Universitario 12 de Octubre; Autonomous University of Barcelona (Spain) |
| 11 | Costa, JFV | University of Valencia; Hospital Universitari i Politècnic La Fe; Hospital Universitario 12 de Octubre (Spain) |
| 12 | Santiago, RF | University of Barcelona; CIBERNED; Hospital Clinic de Barcelona; IDIBAPS Inst Invest Biomed (Spain) |
| 13 | Bandres-Ciga, S | NIH National Institute on Aging (NIA) (USA) |
| 14 | Gómez-Garre, P | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERNED (Spain) |
| 15 | Periñán, MT | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERNED (Spain) |
| 16 | Mir, P | Universidad de Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERNED (Spain) |
| 17 | Pérez-Tur, J | CSIC - Instituto de Biomedicina de Valencia (IBV); CIBERNED (Spain) |
| 18 | Cardona, F | CSIC - Instituto de Biomedicina de Valencia (IBV); CIBERNED (Spain) |
| 19 | Menendez-Gonzalez, M | University of Oviedo (Spain) |
| 20 | Riancho, J | Hospital Universitario Marques de Valdecilla (HUMV); IDIVAL Univ Cantabria (Spain) |
| 21 | Borrego-Hernández, D | Hospital Universitario 12 de Octubre; CIBERER (Spain) |
| 22 | Galán-Dávila, L | Hosp Clin Univ San Carlos (Spain) |
| 23 | Ceberio, JI | Hospital Universitario Marques de Valdecilla (HUMV) (Spain) |
| 24 | Pastor, P | Univ Hosp Germans Trias i Pujol; Germans Trias i Pujol Res Inst IGTP Badalona (Spain) |
| 25 | Paradas, C | Virgen del Rocio University Hospital (Spain) |
| 26 | Dols-Icardo, O | Autonomous University of Barcelona; CIBERNED (Spain) |
| 27 | Traynor, BJ | NIH National Institute on Aging (NIA) (USA) |
| 28 | Feldman, EL | University of Michigan (USA) |
| 29 | University of Michigan (USA) | |
| # | Autoría grupal | Afiliación |
| 30 | Spanish Neurological Consortium | Sin datos () |
